EN
中
Home
About US
Company Overview
Management Team
Therapeutics
Marketed Drugs
Pipeline
Collaborations
R&D and Science
Technology Platforms
Manufacturing
Contact
Contact Us
HOME / Marketed Drugs
Bejescin® (MIL62)
News Time:2026-03-03 11:20:53
For more information, please contact
MIDEA
TEL: 010-67867467-831
EMAIL:pr@mab-works.com
INVESTOR
TEL: 010-67867467-831
EMAIL:ir@mab-works.com